J&J v. Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
Stent patent infringement verdict is set aside by Wilmington, Delaware federal court and a new trial will be held on the charge that Boston Scientific's NIR stent infringes a claim of a Johnson & Johnson patent. An initial damage award of $324.4 mil. to J&J was set aside in March (1"The Gray Sheet" April 1, 2002, In Brief). The judge also entered a "final judgement" that co-defendant Medtronic AVE's stents did not infringe the firm's patents "and stayed further proceedings in the [Boston Scientific] case until after any appeal of that judgment by J&J," Boston Scientific says. J&J plans to appeal...